These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38912931)

  • 1. Identifying chronic kidney disease stage 3 with excess disease burden.
    Campbell A; Chu L; Crittenden S; Sutton A; Boehler A
    Am J Manag Care; 2024 Jun; 30(6):e172-e177. PubMed ID: 38912931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 3. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical costs of CKD in the Medicare population.
    Honeycutt AA; Segel JE; Zhuo X; Hoerger TJ; Imai K; Williams D
    J Am Soc Nephrol; 2013 Sep; 24(9):1478-83. PubMed ID: 23907508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lab-based and diagnosis-based chronic kidney disease recognition and staging concordance.
    Diamantidis CJ; Hale SL; Wang V; Smith VA; Scholle SH; Maciejewski ML
    BMC Nephrol; 2019 Sep; 20(1):357. PubMed ID: 31521124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-cause costs increase exponentially with increased chronic kidney disease stage.
    Golestaneh L; Alvarez PJ; Reaven NL; Funk SE; McGaughey KJ; Romero A; Brenner MS; Onuigbo M
    Am J Manag Care; 2017 Jun; 23(10 Suppl):S163-S172. PubMed ID: 28978205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Neighborhood Model for the Care of Chronic Kidney Disease Patients.
    Smith ZG; McNicoll L; Clark TL; Cohen AJ; Ross AL; Monteiro JF; Dworkin LD
    Am J Nephrol; 2016; 44(4):308-315. PubMed ID: 27657555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CKD Progression in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation Treated With Apixaban Versus Warfarin.
    Wetmore JB; Yan H; Herzog CA; Weinhandl E; Reyes JL; Roetker NS
    Am J Kidney Dis; 2021 Aug; 78(2):180-189. PubMed ID: 33421454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective review of diabetic nephropathy patients during referral to the sub-urban nephrology clinic.
    Menon R; Mohd Noor FS; Draman CR; Seman MR; Ghani AS
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1109-14. PubMed ID: 22982937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.
    Fung E; Chang TI; Chertow GM; Thomas IC; Asch SM; Kurella Tamura M
    Am J Kidney Dis; 2017 Nov; 70(5):705-714. PubMed ID: 28811048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKD stage at nephrology referral and factors influencing the risks of ESRD and death.
    Sud M; Tangri N; Levin A; Pintilie M; Levey AS; Naimark DM
    Am J Kidney Dis; 2014 Jun; 63(6):928-36. PubMed ID: 24485146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Prescription Analgesic Use in Older Adults With and Without Chronic Kidney Disease and Outcomes.
    Han Y; Balkrishnan R; Hirth RA; Hutton DW; He K; Steffick DE; Saran R
    JAMA Netw Open; 2020 Sep; 3(9):e2016839. PubMed ID: 32997126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease.
    Marrufo G; Colligan EM; Negrusa B; Ullman D; Messana J; Shah A; Duvall T; Hirth RA
    JAMA Intern Med; 2020 Jun; 180(6):852-860. PubMed ID: 32227133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An observational study of the quality of care for chronic kidney disease: a Buffalo and Albany, New York metropolitan area study.
    Arora P; Elkin PL; Eberle J; Bono JJ; Argauer L; Murray BM; Ram R; Venuto RC
    BMC Nephrol; 2015 Dec; 16():199. PubMed ID: 26634443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease.
    Herzog CA; Natwick T; Li S; Charytan DM
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1420-1426. PubMed ID: 29909107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
    Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
    Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and transvenous cardiac implantable electronic device infection-is there an impact on healthcare utilization, costs, disease progression, and mortality?
    Wright DJ; Trucco ME; Zhou J; Wolff C; Holbrook R; Margetta J; El-Chami MF
    Europace; 2024 Jul; 26(7):. PubMed ID: 38890126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care costs associated with unrecognized progression to late-stage kidney disease.
    Spencer D; Dunning S; McPheeters J; St Clair Russell J; Hane C
    Am J Manag Care; 2023 Feb; 29(2):e64-e68. PubMed ID: 36811990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaps in Nephrology Referral Care Utilization in Patients at High-Risk of Progression to Kidney Failure.
    Peter S; Wang M; Chu CD; Tuot DS; Chattopadhyay A; Chen JH
    AMIA Annu Symp Proc; 2022; 2022():866-873. PubMed ID: 37128404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes.
    Vupputuri S; Kimes TM; Calloway MO; Christian JB; Bruhn D; Martin AA; Nichols GA
    J Diabetes Complications; 2014; 28(1):10-6. PubMed ID: 24211091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.